^|HP^^9BOIUK$0KDP5($(/YC%;T-PM:>#B
SYSTEM PROCESSING...
^|HP^^9BOIUK$0KDP5($(/YC%;T-PM:>#B
SYSTEM PROCESSING...
Posted: 2025-04-23 18:36:58 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-23 18:37:31 UTC
Verified By
Rollup News
A new study of 2216 people links higher aging scores to increased chronic disease risk and healthcare costs over 5 years, questioning why doctors aren't using these DNA methylation tests more widely despite their potential to predict health risks.
Higher aging scores predict increased risk for myocardial infarction, stroke, diabetes, cancer, liver disease, renal disease, and chronic disease.
DNA methylation tests are gaining traction but lack standardization and are not FDA-approved for clinical decisions.
Tests like TruDiagnostic, EpiAging, and Tally Health are marketed for longevity assessment.
Lack of standardization across labs for DNA methylation tests.
Complexity in interpreting DNA methylation test results.
Tests are not FDA-approved for clinical decisions.